Skip to main content

Table 5 Perinatal outcomes, by fetal presentation of the second twin

From: Outcomes of non-vertex second twins, following vertex vaginal delivery of first twin: a secondary analysis of the WHO Global Survey on Maternal and Perinatal Health

 

Non-vertex n/N, (%) N = 369

Vertex n/N, (%) 1,055

Crude odds ratio (95% CI)

Adjusted odds ratioa(95% CI)

Stillbirth

28/369 (7.6)

50/1055 (4.7)

1.65 (1.02 – 2.66)

1.15 (0.72 – 1.73)

Early neonatal mortality

14/369 (3.8)

22/1055 (2.1)

1.86 (0.94 – 3.67)

1.68 (0.96 – 2.94)

Apgar score <7 at 5 minutes

59/369 (16.0)

120/1050 (11.4)

1.48 (1.05 – 2.07)

1.42 (1.01 – 2.00)*

Admission to NICU

98/369 (26.6)

245/1055 (23.2)

1.20 (0.91 – 1.58)

0.93 (0.62 – 1.39)

  1. aGeneralized linear mixed models adjusted for: maternal age (<20, 20-35, >35), maternal education (0, 1-4, 5-9, > = 10), parity, (0, 1-2, > = 3), antenatal visits (0, 1-3, > = 4), mode of delivery (vaginal or caesarean), hypertensive diseases (chronic or pregnancy-induced hypertension), malaria, other medical diseases (HIV, pregestational diabetes, cardiac/renal disease, chronic respiratory conditions, sickle cell anaemia), prelabour rupture of membranes, pre-eclampsia/eclampsia, vaginal bleeding in 2nd half of pregnancy and urine infection/pyelonephritis, sex, sex discordance (yes/no), gestational age (<37 or > =37 weeks), birthweight (<2500 g or > =2500 g) and birthweight discordance (<15%, larger twin of >15% birthweight discordant pair, smaller twin of >15% birthweight discordant pair); country and facility as random effects.